PMV PharmaceuticalsPMVP +3.48%34 PB Ratio is 0.72 as of Jun. 29, 2026. GuruFocus rates PMVP with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,232 Biotechnology companies, PMV Pharmaceuticals ranks better than 90.02% on this metric.
The historical rank and industry rank for PMV Pharmaceuticals's PB Ratio or its related term are showing as below:
PMVP'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.72
Current: 0.72
During the past 8 years, PMV Pharmaceuticals's highest PB Ratio was 0.72. The lowest was 0.00. And the median was 0.00.
PMVP's PB Ratio is ranked better than 90.02% of 1232
companies
in the Biotechnology industry
Industry Median: 2.835
vs PMVP: 0.72
During the past 12 months, PMV Pharmaceuticals's average Book Value Per Share Growth Rate was -42.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -28.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -23.40% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of PMV Pharmaceuticals was -18.20% per year. The lowest was -28.50% per year. And the median was -20.70% per year.
Back to Basics: PB Ratio
PMV Pharmaceuticals (NAS:PMVP) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PMV Pharmaceuticals PB Ratio Related Terms
PMV Pharmaceuticals PB Ratio Historical Data
* Premium members only.
The historical data trend for PMV Pharmaceuticals's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, PMV Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMV Pharmaceuticals PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PMV Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where PMV Pharmaceuticals's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PMV Pharmaceuticals (PMVP) has a PB Ratio of 0.72 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PMV Pharmaceuticals and its competitors. According to the industry distribution chart, PMV Pharmaceuticals ranks #123 out of 1232 companies in the Biotechnology industry, placing it in the top 10%.
Is PMV Pharmaceuticals' PB Ratio too high?
PMV Pharmaceuticals' current PB Ratio is 0.72. The Biotechnology industry median PB Ratio is 2.84. PMV Pharmaceuticals' value of 0.72 is 74.6% below this industry median. Based on the distribution chart, PMV Pharmaceuticals ranks #123 out of 1232 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PMV Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does PMV Pharmaceuticals' PB Ratio compare to MNOV and TCRX?
According to the Biotechnology industry distribution chart, PMV Pharmaceuticals ranks #123 out of 1232 companies for PB Ratio. This places PMV Pharmaceuticals in the top 10% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.84. PMV Pharmaceuticals' value of 0.72 is 74.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.84, based on 1,232 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMV Pharmaceuticals's current PB Ratio of 0.72 is 74.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PMV Pharmaceuticals and its competitors. For the Biotechnology industry, the median PB Ratio is 2.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMV Pharmaceuticals's current PB Ratio is 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMV Pharmaceuticals stock overvalued right now?
PMV Pharmaceuticals (PMVP) has a current PB Ratio of 0.72. The current PB Ratio is 0.72 and 74.6% below the Biotechnology industry median of 2.84. PMV Pharmaceuticals' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PMV Pharmaceuticals (PMVP), the current PB Ratio is 0.72 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
34GF Score
Get the complete analysis for PMVP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMVP has been successfully added to your 
